These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1384209

  • 1. FK 506 in canine renal transplantation.
    Griffin AD, Hawthorne WJ, Inutsuka S, Chapman JR, Allen RD.
    Transplant Proc; 1992 Oct; 24(5):2305-6. PubMed ID: 1384209
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
    Jiang H, Fujitsu T, Sakuma S, Ogawa T, Tamura K, Fujii Y, Akiyama Y, Izumi S, Takahara S, Ishibashi M.
    Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
    Koefoed-Nielsen PB, Karamperis N, Jørgensen KA.
    Transplant Proc; 2005 May; 37(4):1736-8. PubMed ID: 15919449
    [Abstract] [Full Text] [Related]

  • 12. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
    Ciancio G, Carreno M, Mathew J, Ricordi C, Garcia R, Karatzas T, Fuller L, Cirocco R, Burke G, Webb M, Nery J, Tzakis A, Roth D, Esquenazi V, Miller J.
    Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation.
    Hardie IR, Tiller DJ, Mahony JF, Miach PJ, Thomson NM, Thatcher GN, Rigby RJ, Menzies BL.
    Transplant Proc; 1992 Oct; 24(5):2241-2. PubMed ID: 1413040
    [No Abstract] [Full Text] [Related]

  • 18. Phase III study of FK 506 in kidney transplantation. Japanese FK 506 Study Group.
    Ochiai T, Fukao K, Takahashi K, Endo T, Oshima S, Uchida K, Yokoyama I, Ishibashi M, Takahara S, Iwasaki Y.
    Transplant Proc; 1995 Feb; 27(1):829-33. PubMed ID: 7533435
    [No Abstract] [Full Text] [Related]

  • 19. FK 506 conversion of renal allografts failing cyclosporine immunosuppression.
    Jordan ML, Shapiro R, Jensen CW, Scantlebury V, Fung J, Tzakis A, McCauley J, Jain A, Demetrius J, Randhawa P.
    Transplant Proc; 1991 Dec; 23(6):3078-81. PubMed ID: 1721365
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.